AMDF Funded Research

We believe that funding research is the only way a cure and effective treatments will be developed.
We believe that research will provide treatment options for some of the many symptoms sufferers endure.
We believe that research will uncover methods to stop mitochondrial disease being inherited by the next generation.
We are committed to finding an urgently needed cure for mitochondrial disease and saving lives. The funds raised through the generosity of our donors and sponsors are directed into key research areas that we believe will give us the biggest chance of achieving this goal.

In 2017, AMDF approved an allocation of $2.5 million in additional funding towards research and medical initiatives as part of its revised Research and Medical Funding Strategy. The funding will bolster existing research grants, and has led to the establishment of two new grants: AMDF Booster Grants and AMDF Research Fellowships.

AMDF Research Funding Focus

AMDF’s research funding is focussed on understanding the biology of primary disorders of energy generation and improving their diagnosis, treatment, prevention and cures.

AMDF Research Funding Opportunities


AMDF Booster Grants

 

AMDF Booster Grants offer an exciting opportunity for those whose research was deemed of a high quality by the NHMRC but were unsuccessful in securing funding.

Booster Grants provide up to $75,000 worth of funding, and may assist in securing future NHMRC funding.

Funding Round
The next funding round will be opened after the NHMRC funding announcement in 2018. Please check back for updates.

Read more about Booster Grants



AMDF Clinical Trial Support Grants

 

Clinical trials in mitochondrial disease are almost non-existent in Australia. AMDF is eager for more pharmaceutical companies to see Australia as a viable location to conduct clinical trials. For Australia to be a candidate for clinical trials, infrastructure must be in place. This infrastructure can include venues and staff to run the trial, Internet resources, and bio-banking facilities.

AMDF Clinical Trial Grants are up to $75,000 per year for three years.

Funding Round
Open: 1 January 2018
Close: 23 March 2018

Read more about AMDF Clinical Trial Support Grants.



AMDF Incubator Grants

 

Research into mitochondria and genetics only began to take shape during the 1990s, which makes this a very exciting time to be a mitochondrial disease researcher. Many funding bodies require the researcher to have a significant track record of investigation and the research project to have some initial evidence. It is, therefore, difficult to establish some areas of study due to the fact that mitochondrial medicine is a relatively new field.

AMDF Incubator Grants bridge this gap by facilitating preliminary investigation and enabling the researcher to reach a point where they are then eligible to apply to external/independent bodies for funding to complete their research.

AMDF Incubator Grants up to $25,000 are awarded for projects up to 12 months duration.

Funding round
PhD Top-Up Scholarships are available throughout the year.

Read more about AMDF Incubator Grants.



AMDF PhD Top-Up Scholarships

 

AMDF PhD Top-Up Scholarships attract Australia’s best young scientists to the field of mitochondrial disease. By encouraging scientists at the beginning of their career, the goal is that they will continue their careers in mitochondrial disease research.

AMDF PhD Top-Up Scholarships “top-up” researcher’s existing NHMRC, ARC or similar scholarship for up to three years. AMDF PhD Top-Up Scholarships comprise two components:
1) a top-up amount of $3,000 per year
2) a $3,000 per year travel allowance

Funding round
PhD Top-Up Scholarships are available throughout the year.

Read more about AMDF PhD Top-Up Scholarships.



AMDF Research Equipment Grants

Research equipment grants are available to researchers who are unable to access certain pieces of equipment that are vital, or would greatly advance their work.

AMDF Research Equipment Grants up to $50,000 aim to supplement the funding provided by the laboratory or other funding sources for the purchase of the equipment.

Read more about AMDF Research Equipment Grants.


AMDF Research Fellowships

AMDF Research Fellowships support early career researchers to develop a track record in mitochondrial disease research.

AMDF Research Fellowships are charitable grants of $100,000 per year for two years, offered to researchers to assist with their work on mitochondrial disorders.

Funding Round
Open: 1 January 2018
Close: 23 March 2018

Find out more about Research Fellowships


Research Project Grants

 

One of AMDF’s key goals is to boost research into mitochondrial disease research. In some instances this research may not fit neatly into one of the prescribed AMDF research funding opportunities. AMDF will consider all applications for funding to support the highest quality research in the field of mitochondrial disease.

Read more about AMDF Research Project Grants



AMDF Translational Research Grants

The aim of the AMDF Translational Research Grants is to rapidly transform research discoveries into clinical practice. AMDF fund exceptional researchers who have the capability to turn around ground breaking research and start to make inroads into treatments.

AMDF Translational Research Grants are up to $150,000 per year for two years.

Funding Round
Open: 1 January 2018
Close: 23 March 2018

Read more about AMDF Translational Research Grants.

Australian Competitive Grants Register

AMDF aspires to attain inclusion on the Australian Competitive Grants Register by the time its research funding meets the minimum eligible amount (currently $1m per annum for research programmes excluding PhD Scholarships and equipment funding).

To download a copy of the AMDF Research Strategy, click here. 

Research Spotlight

DNA Helix Image

Research Project Grant

AGHA: Preparing Australia for Genomic Medicine

AMDF, along with the Australian Genomic Health Alliance, has co-funded this study whichs aims to test 200 Australians suspected of having mitochondrial disease. The study will evaluate the effectiveness and cost efficiency of genomic testing.

Until now, the implementation of genomic testing has been uncoordinated, leading to inefficient outcomes and unnecessary costs. The study will provide an evidence base for the implementation of genomic testing across Australia. Find out more.

Kara Perks in the lab

PhD Top-Up Scholarship

Kara Perks

Kara, a PhD candidate at the University of Western Australia, is undertaking research to understand the link between impaired gene expression and mitochondrial disease. She is using cutting-edge technology to investigate how processes inside mitochondria can be impaired, producing proteins that may cause mitochondrial dysfunction.

Through discovering how certain molecules affect mitochondria, Kara’s research lays the groundwork for drug design and therapeutic intervention, taking us a step closer to a viable treatment. Find out more.